Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) Price Target at $111.75

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) has received an average rating of "Buy" from the twelve brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $111.75.

A number of equities analysts recently issued reports on HQY shares. Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group reduced their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, KeyCorp cut their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th.

HealthEquity Stock Performance

Shares of HQY traded down $0.87 on Friday, reaching $97.19. The company's stock had a trading volume of 291,933 shares, compared to its average volume of 791,251. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market capitalization of $8.41 billion, a P/E ratio of 89.02, a PEG ratio of 1.60 and a beta of 0.45. The stock's 50 day simple moving average is $87.77 and its two-hundred day simple moving average is $96.82. HealthEquity has a 12-month low of $65.01 and a 12-month high of $115.59.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now directly owns 84,969 shares in the company, valued at $6,597,842.85. The trade was a 6.34% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.

Hedge Funds Weigh In On HealthEquity

Large investors have recently made changes to their positions in the company. Barclays PLC increased its holdings in HealthEquity by 209.3% in the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after acquiring an additional 112,667 shares in the last quarter. GAMMA Investing LLC raised its position in shares of HealthEquity by 32.9% in the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock valued at $120,000 after buying an additional 309 shares during the last quarter. Nordea Investment Management AB grew its holdings in shares of HealthEquity by 4.8% in the fourth quarter. Nordea Investment Management AB now owns 59,812 shares of the company's stock valued at $5,747,000 after purchasing an additional 2,757 shares during the period. Assenagon Asset Management S.A. purchased a new stake in shares of HealthEquity in the fourth quarter valued at about $1,452,000. Finally, Covea Finance purchased a new position in HealthEquity during the fourth quarter worth about $1,727,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.